Task: Answer the multiple-choice question.
Query: Which drug exhibits a -21.229% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccc(Cl)cc1S(=O)(=O)N1CCC(C(=O)NC2CCCC2)CC1
b CC(C)Nc1ncnc2c1cnn2-c1ccc(Cl)cc1
c COc1ccc(OC)c(/C=N/NC(=O)CN2CCSCC2)c1
Answer: a. COc1ccc(Cl)cc1S(=O)(=O)N1CCC(C(=O)NC2CCCC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1S(=O)(=O)N1CCC(C(=O)NC2CCCC2)CC1
COc1ccc(Cl)cc1S(=O)(=O)N1CCC(C(=O)NC2CCCC2)CC1
1-(5-chloro-2-methoxyphenyl)sulfonyl-N-cyclopentylpiperidine-4-carboxamide